| General information | Literature | Expression | Regulation | Mutation | Interaction |
|
Basic Information |
|
|---|---|
Gene ID | 185 |
Name | AGTR1 |
Synonymous | AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R;angiotensin II receptor, type 1;AGTR1;angiotensin II receptor, type 1 |
Definition | type-1 angiotensin II receptor|type-1B angiotensin II receptor |
Position | 3q24 |
Gene type | protein-coding |
|
Title |
Abstract |
| The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer. | Gastric cancer with peritoneal dissemination has poor clinical prognosis because of the presence of rich stromal fibrosis and acquired drug resistance. Recently, Angiotensin II type I receptor blockers such as candesartan have attracted attention for their potential anti-fibrotic activity. We examined whether candesartan could attenuate tumor proliferation and fibrosis through the interaction between gastric cancer cell line (MKN45) cells and human peritoneal mesothelial cells. Candesartan significantly reduced TGF-beta1 expression and epithelial-to-mesenchymal transition-like change, while tumor proliferation and stromal fibrosis were impaired. Targeting the Angiotensin II signaling pathway may therefore be an efficient strategy for treatment of tumor proliferation and fibrosis. |